glp-1 levels in type 2 diabetes RA education GLP-1 Drugs: Fighting Diabetes and

District Judge Karen Marston has ruled that plaintiffs in the Ozempic and related GLP-1 litigation must confirm gastroparesis diagnoses with a gastric emptying study

When prescribing is supervised and thoughtful, these medicines are effective and safe. Louwagie agrees that the case report highlights the need for individualized care

Pretreatment with liraglutide (25 nmol/kg

Bergenstal RM, Li Y, Porter TKB, Weaver C, Han J

Patients with existing heart or kidney disease may benefit from starting SGLT-2 inhibitors therapy, while those with a higher risk of developing these conditions, such as obese patients and those with no cardiogenic stroke, may benefit more from GLP-1 RAs

The rising prevalence of these chronic conditions has led to an increased demand for effective treatments, including GLP-1 analogues, to control diabetes and weight